Literature DB >> 25859484

Osteoblastic and osteoclastic metastases in a single vertebra-a rare presentation.

Gian Chand1, Ajay Chhabra2, Deepshikha Mangat3, Suparna Grover4.   

Abstract

Malignancies may produce bony metastases which may be osteoclastic or osteoblastic. Vertebrae are a common site for bony metastases. Prostatic adenocarcinoma is an important source of vertebral metastases that are mainly osteoblastic in nature. As the osteoblastic metastases are developing there is an ongoing osteoclastic activity which is going on at the microscopic level. Presence of gross osteoblastic and osteoclastic lesions, in the same vertebra, have not been reported at the time of presentation. Here a rare case of vertebral metastases is being presented which shows osteoblastic and osteoclastic gross lesions in the same vertebra.

Entities:  

Keywords:  Metastasis; Osteoblastic; Osteoclastic; Prostate

Year:  2015        PMID: 25859484      PMCID: PMC4378766          DOI: 10.7860/JCDR/2015/11237.5543

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Effects of basic fibroblast growth factor on bone formation in vitro.

Authors:  E Canalis; M Centrella; T McCarthy
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Histopathological assessment of prostate cancer bone osteoblastic metastases.

Authors:  Martine P Roudier; Colm Morrissey; Lawrence D True; Celestia S Higano; Robert L Vessella; Susan M Ott
Journal:  J Urol       Date:  2008-07-18       Impact factor: 7.450

4.  Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen.

Authors:  M Iwamura; J Hellman; A T Cockett; H Lilja; S Gershagen
Journal:  Urology       Date:  1996-08       Impact factor: 2.649

5.  Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

Authors:  Klaus Jung; Michael Lein; Carsten Stephan; Katharina Von Hösslin; Axel Semjonow; Pranav Sinha; Stefan A Loening; Dietmar Schnorr
Journal:  Int J Cancer       Date:  2004-09-20       Impact factor: 7.396

6.  Complete amino acid sequence of human transforming growth factor type beta 2.

Authors:  H Marquardt; M N Lioubin; T Ikeda
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

Review 7.  Primary bone and metastatic tumors of the cervical spine.

Authors:  W A Abdu; M Provencher
Journal:  Spine (Phila Pa 1976)       Date:  1998-12-15       Impact factor: 3.468

8.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 9.  Role of stromal-derived cytokines and growth factors in bone metastasis.

Authors:  G David Roodman
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Authors:  J B Nelson; S P Hedican; D J George; A H Reddi; S Piantadosi; M A Eisenberger; J W Simons
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.